2,920
Participants
Start Date
February 1, 2024
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Quality Improvement
Rapid Point-of-Care testing will provide participants with a HCV antibody and RNA result within 2 hours. If the participant is HCV RNA+, they will receive an inpatient consultation from a liver specialist prior to discharge. We hypothesize that this model will minimize losses in the continuum-of-care and improve linkages to care.
RECRUITING
Toronto General Hospital, Toronto
RECRUITING
Toronto Western Hospital, Toronto
Jordan Feld
OTHER